Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 19 | 0 | 2 | 0 | €99.54 | €116.25 | 16.785% |
| AbbVie Inc. | 32 | 0 | 7 | 0 | €173.94 | €180.29 | 3.650% |
| Abeona Therapeutics Inc. | 6 | 1 | 1 | 0 | €4.06 | €19.31 | 375.603% |
| Acadia Healthcare | 1 | 0 | 1 | 0 | €64.50 | - | - |
| Acadia Pharmaceuticals | 35 | 1 | 8 | 0 | €14.31 | €29.92 | 109.052% |
| Addus Homecare Corp. | 23 | 1 | 4 | 0 | €109.00 | €114.18 | 4.754% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| Agilent Technologies Inc. | 16 | 4 | 1 | 0 | €125.38 | €133.94 | 6.830% |
| Agios Pharmaceuticals Inc. | 9 | 1 | 1 | 0 | €40.00 | €48.75 | 21.874% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €22.56 | €38.62 | 71.202% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €4.68 | - | - |
| Allscripts Healthcare | 2 | 0 | 0 | 0 | €8.00 | €11.95 | 49.394% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €247.10 | €271.69 | 9.952% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €88.00 | €92.26 | 4.841% |
| Amgen Inc. | 28 | 0 | 4 | 0 | €295.30 | €304.82 | 3.223% |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €9.00 | €17.64 | 95.974% |
| Amneal Pharmaceuticals Inc | 1 | 0 | 0 | 0 | €7.00 | €10.00 | 42.857% |
| AnaptysBio Inc | 10 | 1 | 2 | 0 | €30.60 | €48.33 | 57.930% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €23.60 | €28.29 | 19.876% |
| Applied Therapeutics Inc | 2 | 1 | 1 | 0 | €5.67 | €7.00 | 23.457% |
| Atossa Genetics Inc | 10 | 0 | 0 | 0 | €1.10 | €4.66 | 325.146% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €9.20 | €10.00 | 8.696% |
| Axonics Modulation Technologies Inc | 5 | 0 | 0 | 0 | €59.50 | €66.12 | 11.119% |
| Baxter International | 4 | 0 | 0 | 0 | €34.02 | €46.00 | 35.200% |
| Becton, Dickinson & Co. | 10 | 0 | 3 | 0 | €216.10 | €257.91 | 19.347% |